Graft-versus-host Disease (GVHD)
Also known as: Graft Versus Host Disease (cGvHD) / GVHD - Graft-Versus-Host Disease / Graft-versus-host-disease (GVHD) / Graft Vs Host Disease / Graft vs. Host Disease / Graft-Versus-Host-Disease / Graft vs. Host Disease (GvHD) / Graft-Versus-Host Disease / GvHD / Graft-Vs-Host Disease / Graft-vs-Host Disease (GVHD) / Graft Versus Host Disease (GVHD) / Graft Versus Host Disease / Graft versus host disease [Ambiguous] / Graft-versus-host disease
| Drug | Drug Name | Drug Description |
|---|---|---|
| DB09312 | Antilymphocyte immunoglobulin (horse) | A primarily IgG immune globulin used to manage allograft rejection in renal transplant patients. |
| DB00091 | Cyclosporine | A steroid-sparing immunosuppressant used in organ and bone marrow transplants as well as inflammatory conditions such as ulcerative colitis, rheumatoid arthritis, and atopic dermatitis. |
| DB00005 | Etanercept | A protein therapy based on the binding fragment of the tumour necrosis factor alpha receptor used to treat severe rheumatoid arthritis and moderate to severe plaque psoriasis. |
| DB00563 | Methotrexate | An antineoplastic agent used the treatment of a wide variety of cancers as well as severe psoriasis, severe rheumatoid arthritis, and juvenile rheumatoid arthritis. |
| DB01263 | Posaconazole | A triazole antifungal drug that is used to treat invasive infections by Candida species and Aspergillus species in severely immunocompromised patients. |
| DB00877 | Sirolimus | An mTOR inhibitor immunosuppressant used to prevent organ transplant rejections, treat lymphangioleiomyomatosis, and treat adults with perivascular epithelioid cell tumors. |
| DB00864 | Tacrolimus | A calcineurin inhibitor used to prevent organ transplant rejection and to treat moderate to severe atopic dermatitis. |